Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - topotecan hydrochloride - solution for infusion - 1mg/1ml

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - topotecan hydrochloride - powder for solution for infusion - 1mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - topotecan hydrochloride - powder for solution for infusion - 4mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - topotecan hydrochloride - powder for solution for infusion - 4mg

Соединенные Штаты - английский - NLM (National Library of Medicine)

mylan institutional llc - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan 4 mg in 1 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

sagent pharmaceuticals - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan hydrochloride 4 mg in 4 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

three rivers pharmaceuticals, llc. - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan hydrochloride 4 mg in 4 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan 4 mg in 4 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

sagent pharmaceuticals - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan hydrochloride 4 mg in 4 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

janssen products, lp - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) - doxorubicin hydrochloride 2 mg in 1 ml - doxorubicin hydrochloride liposome injection is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy. doxorubicin hydrochloride liposome injection is indicated for the treatment of aids-related kaposi's sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy. doxorubicin hydrochloride liposome injection, in combination with bortezomib, is indicated for the treatment of patients with multiple myeloma who have not previously received bortezomib and have received at least one prior therapy. doxorubicin hydrochloride liposome injection is contraindicated in patients who have a history of severe hypersensitivity reactions, including anaphylaxis, to doxorubicin hydrochloride [see warnings and precautions (5.2)]. risk summary based on findings in animals and its mechanism of action, doxorubicin hydrochloride liposome injection can cause fetal harm when administered to a pregnant woman; avoid the